BR9004626A - Processo para preparar um concentrado estavel de complexo de fator viii-fator de von willebrand,concentrado de complexo de fator viii-fator de von willebrand e concentrados de proteina derivados de plasma - Google Patents

Processo para preparar um concentrado estavel de complexo de fator viii-fator de von willebrand,concentrado de complexo de fator viii-fator de von willebrand e concentrados de proteina derivados de plasma

Info

Publication number
BR9004626A
BR9004626A BR909004626A BR9004626A BR9004626A BR 9004626 A BR9004626 A BR 9004626A BR 909004626 A BR909004626 A BR 909004626A BR 9004626 A BR9004626 A BR 9004626A BR 9004626 A BR9004626 A BR 9004626A
Authority
BR
Brazil
Prior art keywords
concentrate
factor
von willebrand
factor viii
plasma
Prior art date
Application number
BR909004626A
Other languages
English (en)
Inventor
Miryana Burnouf-Radosevich
Thierry Burnouf
Original Assignee
Centre Regional De Transfusion
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Regional De Transfusion filed Critical Centre Regional De Transfusion
Priority to BR909004626A priority Critical patent/BR9004626A/pt
Publication of BR9004626A publication Critical patent/BR9004626A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
BR909004626A 1989-09-05 1990-09-17 Processo para preparar um concentrado estavel de complexo de fator viii-fator de von willebrand,concentrado de complexo de fator viii-fator de von willebrand e concentrados de proteina derivados de plasma BR9004626A (pt)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BR909004626A BR9004626A (pt) 1989-09-05 1990-09-17 Processo para preparar um concentrado estavel de complexo de fator viii-fator de von willebrand,concentrado de complexo de fator viii-fator de von willebrand e concentrados de proteina derivados de plasma

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8911567A FR2651437A1 (fr) 1989-09-05 1989-09-05 Procede de preparation de concentre du complexe facteur viii-facteur von willebrand de la coagulation sanguine a partir de plasma total.
BR909004626A BR9004626A (pt) 1989-09-05 1990-09-17 Processo para preparar um concentrado estavel de complexo de fator viii-fator de von willebrand,concentrado de complexo de fator viii-fator de von willebrand e concentrados de proteina derivados de plasma

Publications (1)

Publication Number Publication Date
BR9004626A true BR9004626A (pt) 1992-03-24

Family

ID=9385124

Family Applications (1)

Application Number Title Priority Date Filing Date
BR909004626A BR9004626A (pt) 1989-09-05 1990-09-17 Processo para preparar um concentrado estavel de complexo de fator viii-fator de von willebrand,concentrado de complexo de fator viii-fator de von willebrand e concentrados de proteina derivados de plasma

Country Status (24)

Country Link
US (1) US5679776A (pt)
EP (1) EP0416983B1 (pt)
AT (1) ATE91896T1 (pt)
AU (1) AU627618B2 (pt)
BR (1) BR9004626A (pt)
CA (1) CA2024667C (pt)
CZ (1) CZ277939B6 (pt)
DD (1) DD298110A5 (pt)
DE (1) DE69002427T2 (pt)
DK (1) DK0416983T3 (pt)
ES (1) ES2057475T3 (pt)
FI (1) FI95654C (pt)
FR (1) FR2651437A1 (pt)
HR (1) HRP920768B1 (pt)
HU (1) HU206378B (pt)
LT (1) LT3418B (pt)
LV (1) LV10053B (pt)
NO (1) NO178716C (pt)
PL (1) PL164754B1 (pt)
RU (1) RU2025129C1 (pt)
SI (1) SI9012034B (pt)
SK (1) SK431290A3 (pt)
UA (1) UA26847C2 (pt)
YU (1) YU48356B (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3904354A1 (de) * 1989-02-14 1990-08-16 Behringwerke Ag Pasteurisiertes, gereinigtes von willebrand-faktor-konzentrat und verfahren zu seiner herstellung
EP0399321B1 (en) * 1989-05-24 1993-06-23 Miles Inc. Gel filtration of heat treated factor viii
AT403991B (de) * 1990-04-04 1998-07-27 Atomic Austria Gmbh Alpinschi
AT403992B (de) * 1991-02-22 1998-07-27 Head Sport Ag Ski
DE4204694C3 (de) * 1992-02-01 1995-10-12 Octapharma Ag Verfahren zur Gewinnung von hochreinem, virusinaktiviertem Faktor VIII mittels Anionenaustauscher-Chromatographie
IT1256622B (it) * 1992-12-04 1995-12-12 Sclavo Spa Processo per l'estrazione del complesso fattore viii-fattore von willebrand (fviii:c-fvw) da plasma umano totale.
DE4430205A1 (de) * 1994-08-26 1996-02-29 Behringwerke Ag Zusammensetzungen, die als Gegenmittel für Blut-Antikoagulanzien geeignet sind und deren Verwendung
DE4435485C1 (de) * 1994-10-04 1996-03-21 Immuno Ag Verfahren zur Gewinnung von hochreinem von Willebrand-Faktor
AT403764B (de) 1996-03-15 1998-05-25 Immuno Ag Stabiler faktor viii/vwf-komplex
AT403765B (de) 1996-04-12 1998-05-25 Immuno Ag Verfahren zur herstellung einer präparation enthaltend einen hochgereinigten komplex
AT406373B (de) 1997-02-27 2000-04-25 Immuno Ag Verfahren zur reinigung von faktor viii/vwf-komplex mittels kationenaustauscherchromatographie
AU9651498A (en) * 1997-11-05 1999-05-24 Yoshitomi Pharmaceutical Industries, Ltd. Heparin cofactor ii preparations and process for producing the same
ES2193499T3 (es) 1998-02-11 2003-11-01 Zlb Bioplasma Ag Un metodo para la eliminacion de un agente o agentes causantes de encefalopatias espongiformes transmisibles de soluciones proteinicas.
DK2193809T3 (en) 1999-02-22 2015-05-26 Univ Connecticut The albumin-free Factor VIII formulation
DE19937218A1 (de) 1999-08-06 2001-02-08 Aventis Behring Gmbh Verfahren zur Reindarstellung der den Blutgerinnungsfaktor VII aktivierenden Protease, ihres Proenzyms oder eines Gemisches beider Proteine mittels Affinitätschromatographie
ES2229931B1 (es) * 2003-10-03 2006-01-16 Grifols, S.A. Composicion liquida bilogicamente estable de fviii, de fvw o del complejo fviii/fvw humanos.
FR2874216B1 (fr) * 2004-08-16 2006-11-03 Lab Francais Du Fractionnement Procede de preparation d'un concentre de facteur von willebrand (fvw) par voie chromatographique et concentre de fvw susceptible d'etre ainsi obtenu
MX339060B (es) 2008-11-07 2016-05-09 Baxter Int Formulaciones del factor viii.
WO2013083858A1 (en) 2012-04-24 2013-06-13 Novo Nordisk A/S Compounds suitable for treatment of haemophilia
CN105705516B (zh) 2013-11-08 2019-11-01 杰特有限公司 浓缩von Willebrand因子或其络合物的方法
US9663553B2 (en) 2014-01-29 2017-05-30 Hemarus Therapeutics Limited Integrated process for the production of therapeutics (human albumin, immunoglobulins, clotting factor VIII and clotting factor IX) from human plasma
CN104231073B (zh) * 2014-09-25 2017-01-25 广东双林生物制药有限公司 一种人凝血因子viii的制备方法
CN105315365A (zh) * 2015-11-17 2016-02-10 上海洲跃生物科技有限公司 一种人抗凝血酶iii的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3803115A (en) * 1972-05-17 1974-04-09 Baxter Laboratories Inc Stabilization of ahf using heparin
ES471858A1 (es) * 1977-07-25 1979-02-01 Monsanto Co Un metodo para separar el factor especifico de coagulacion de la sangre de una mezcla con otras proteinas de la sangre en un medio fluido
US4386068A (en) * 1980-02-26 1983-05-31 Cutter Laboratories, Inc. Antihemophilic factor concentrate and method for preparation
US4359463A (en) * 1980-11-26 1982-11-16 Rock Gail A Stabilization of Factor VIII activity in whole blood or blood plasma
US4435318A (en) * 1981-05-22 1984-03-06 Ionics, Incorporated Electrodialysis preparation of purified AHF concentrate
US4361509A (en) * 1981-12-14 1982-11-30 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
US4495175A (en) * 1982-08-05 1985-01-22 University Of Rochester Preparation of highly purified human antihemophilic factor
US4543210A (en) * 1984-10-04 1985-09-24 Miles Laboratories, Inc. Process for producing a high purity antihemophilic factor concentrate
US4952675A (en) * 1985-02-01 1990-08-28 New York University Method for purifying antihemophilic factor
FR2632309B1 (fr) * 1988-06-07 1990-08-24 Lille Transfusion Sanguine Procede de purification par voie chromatographique de proteines, notamment de facteur viii, et les produits obtenus

Also Published As

Publication number Publication date
NO178716B (no) 1996-02-12
UA26847C2 (uk) 1999-12-29
PL164754B1 (pl) 1994-10-31
NO178716C (no) 1996-05-22
SI9012034B (sl) 1999-12-31
SK279367B6 (sk) 1998-10-07
YU48356B (sh) 1998-07-10
EP0416983A1 (fr) 1991-03-13
HRP920768A2 (en) 1995-02-28
FI95654B (fi) 1995-11-30
DE69002427D1 (de) 1993-09-02
CA2024667C (en) 2001-07-31
LTIP263A (en) 1994-10-25
FR2651437A1 (fr) 1991-03-08
CZ431290A3 (en) 1993-01-13
FR2651437B1 (pt) 1994-08-19
DE69002427T2 (de) 1993-12-23
AU627618B2 (en) 1992-08-27
FI904381A0 (fi) 1990-09-05
LV10053A (lv) 1994-05-10
FI95654C (fi) 1996-03-11
DK0416983T3 (da) 1993-10-04
ATE91896T1 (de) 1993-08-15
HU905797D0 (en) 1991-03-28
NO903865L (no) 1991-03-06
AU6221890A (en) 1992-03-12
SI9012034A (en) 1997-10-31
NO903865D0 (no) 1990-09-05
PL286746A1 (en) 1991-05-06
LT3418B (en) 1995-09-25
SK431290A3 (en) 1998-10-07
HUT56858A (en) 1991-10-28
DD298110A5 (de) 1992-02-06
CZ277939B6 (en) 1993-06-16
LV10053B (en) 1995-02-20
HU206378B (en) 1992-10-28
HRP920768B1 (en) 1998-12-31
US5679776A (en) 1997-10-21
EP0416983B1 (fr) 1993-07-28
ES2057475T3 (es) 1994-10-16
YU203490A (sh) 1993-05-28
RU2025129C1 (ru) 1994-12-30
CA2024667A1 (en) 1991-03-06

Similar Documents

Publication Publication Date Title
BR9004626A (pt) Processo para preparar um concentrado estavel de complexo de fator viii-fator de von willebrand,concentrado de complexo de fator viii-fator de von willebrand e concentrados de proteina derivados de plasma
UA11061A (uk) Спосіб розділеhhя білків крові
DK0399666T3 (da) Fusionsproteiner indeholdende N-terminalfragmenter af human serumalbumin
DE69024105D1 (de) Verfahren zur Herstellung von gereinigten Albuminlösungen
DK0567448T3 (da) Fremgangsmåde til fremstilling af faktor VIII
ES2053684T3 (es) Procedimiento para preparar un factor antihemofilico, altamente puro, no infeccioso, mediante cromatografia.
ES2055875T3 (es) Procedimiento de fabricacion del factor antihemofilico (fviiic) con una pureza muy elevada.

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal